Haisu Dai
Overview
Explore the profile of Haisu Dai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dai H, Jiang Y, Liu Z, Su X, Yang Y, Chen Z
Can J Gastroenterol Hepatol
. 2024 Sep;
2022:9202531.
PMID: 39296516
Our previous studies showed that Pumilio RNA-binding family member 1 (PUM1) gene is abnormally expressed in pancreatic cancer (PC) tissues, and its knockdown suppresses the growth and metastasis of PC...
2.
Gong Y, Dai H, Liu W, Liao R, Chen H, Zhang L, et al.
FASEB J
. 2023 Feb;
37(3):e22782.
PMID: 36786721
Ischemia-reperfusion (I/R) injury is a crucial factor causing liver injury in the clinic. Recent research has confirmed that human adipose-derived stem cells (ADSCs) can differentiate into functional hepatocytes. However, the...
3.
Song J, Lei X, Lin H, Dai H, Liu X, Jiang Y, et al.
PLoS One
. 2022 Apr;
17(4):e0258522.
PMID: 35417458
Introduction: Surgical exploration is widely performed in hilar cholangiocarcinoma (HCCA), but the intraoperative resectability rate is only 60%-80%. Exploration substantially increases pain and mental stress, and the costs and length...
4.
Yang Y, Su X, Shen K, Zhang C, Dai H, Ma H, et al.
Transl Cancer Res
. 2022 Feb;
10(5):2153-2168.
PMID: 35116535
Background: Pancreatic carcinoma (PAAD) is a highly malignant cancer with a poor prognosis and high mortality rate. Pumilio homologous protein 1 (PUM1) promotes cell growth, invasion, and metastasis and suppresses...
5.
Qin H, Hu X, Zhang J, Dai H, He Y, Zhao Z, et al.
Liver Int
. 2020 Dec;
41(4):837-850.
PMID: 33306240
Background And Aims: Up to 40%-65% of patients with perihilar cholangiocarcinoma (PHC) rapidly progress to early recurrence (ER) even after curative resection. Quantification of ER risk is difficult and a...
6.
Su X, Yang Y, Ma L, Luo P, Shen K, Dai H, et al.
Onco Targets Ther
. 2020 Dec;
13:12213-12223.
PMID: 33273827
Introduction: Pancreatic cancer is one of the deadliest cancers in the world, and pancreatic ductal adenocarcinoma (PDAC) accounts for 90% of all cases. Human positive coactivator 4 (PC4) is a...
7.
8.
Dai H, Shen K, Yang Y, Su X, Luo Y, Jiang Y, et al.
Cell Death Dis
. 2019 Aug;
10(8):595.
PMID: 31395860
Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with very poor prognosis. Therefore, it is important to fully understand the molecular mechanism underlying its occurrence and development. Pumilio RNA-binding family...
9.
Wang A, Dai H, Gong Y, Zhang C, Shu J, Luo Y, et al.
J Exp Clin Cancer Res
. 2019 Aug;
38(1):347.
PMID: 31395079
Background: Pancreatic cancer is a highly lethal malignancy with poor prognosis. Anillin (ANLN), an actin binding protein, is upregulated and plays an important role in many malignant tumors. However, the...
10.
Dai H, Jiang Y, Luo Y, Bie P, Chen Z
Phytomedicine
. 2019 May;
62:152953.
PMID: 31128486
Background: Triptolide (TPL) can enhance the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), but available research is limited to whether TPL can affect the relevant...